skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello 5i
Could you please provide me with the best Palladium and Neon play out there please? Please mention why you like the choice. Would it be better to side with Neon
as its supply from Mariupol and Odessa (Ingas and Cryoin) will be affected for a long time...or 37% of Pallidium comes from Russia and that will probably never come back to markets here. Or is there another element in chip manufacturing that you are thinking of?
Thank you
J
Read Answer Asked by Jeremy on March 18, 2022
Q: Hello Peter and team,
The market is up today and the tech stocks are up considerably after the recent fed rate increase. Is it because the increase was small (i.e Tech stocks sold off on previous announcements of rate increases)? Any idea why Tecsys and ATS automation are not participating? Do you see Arc Resources and Whitecap doing better in the next few months.. On BNN, Eric Nuttal, felt oil will continue to do well price wise. Do you share that view?
Read Answer Asked by umedali on March 18, 2022
Q: For the past 4 years or so, DFN fund management has increased the share count via bought deal, two times a year. While it should not matter in DFN's case because of it's business model, each share increase has caused the stock to tumble. It then creeps slowly upwards until the next increase causes it to tumble again. Some months ago DFN announced the "At-The-Market Equity Program" is renewed.

What does "At-The-Market Equity Program" mean? Presumably it also means they can still do large bought deals when the price is high, just that it won't be as predictable as the past years spring and fall issuance..?

Thanks for the ongoing great service.
Read Answer Asked by Mark on March 18, 2022
Q: Hi Team,

I realize this question might be off the beaten track but was hoping you might be able to shed some light on the implications of holding a debenture issued by Cominar now that it is experiencing a change in control in favour of Iris Acquisition II LP.

I have received a corporate action notification that I have an option to receive $1010 CAD for every $1000 CAD principal amount of Cominar Real Estate Investment Trust 4.5% Series 11 Senior Unsecured Debentures due May 15, 2024 tendered. With no action on my part, debentures in respect of which the Optional Put Right is not exercised will remain obligations of Cominar under the terms and conditions of the Indenture and will continue to accrue interest in accordance with the terms of the Indenture.

Any idea in plain english if the debt obligation has a higher risk profile to the holder if the option is not taken? If you were the holder, would you exercise the option or do nothing?

Many thanks.
Michael
Read Answer Asked by Michael on March 18, 2022
Q: I understand that JPM is processing Russian bond interest payments. Please explain JPM’s role. Are they supporting the Russian economy by doing this? I am considering selling my small position in JPM. Does this make sense or is it simply naive? Thanks as always
Read Answer Asked by Frank on March 17, 2022
Q: I received Class Action Notice for the above company dated March 1, 2022. It seems I am qualified to participate in the settlement as I purchased securities during the period Feb. 23, 2018, to Oct. 15, 2018. Specifically, I bought 413 RHT shares at $1.81 on June 21, 2018, and sold at $0.365 on Oct. 17, 2018. If I submit the Claim form how this would benefit me? Would Confirmation of Purchase and Sell documents from the TD be sufficient proof of ownership documents? As always, thanks for your comments.
Read Answer Asked by Hali on March 17, 2022
Q: I hold both NGD (about 1.7% position) and AR (currently about 0.8% position, but initiated at about 1.5%) among my positions in precious metals. AR corrected significantly over the last few months, but the share price seems to be rebounding since lows were established shortly after the New Year. Both NGD and AR have been outmatched by KRR (just about 3% position) , which has performed spectacularly over the last several months. I feel like I am decently positioned with KRR, and was wondering your thoughts on consolidating positions around either NGD or AR. Would this be worthwhile, or is staying put the more prudent approach for this issue? Alternatively, would you suggest selling both and initiating a position elsewhere, or further increasing my position in KRR?

As always, I look forward to your comments, and appreciate your insights.
Read Answer Asked by Domenic on March 17, 2022
Q: Hello Peter and team, I have held a position in the company for more than 10 years. It has been a roller coaster ride with a couple of boom and bust along the way. Recently, it has been recovering fast, with Covid restrictions lifting and people going back to offices. Does this run up have more legs? Is it time to trim? What will the rising interest affect REITS in general? Do you see better opportunities in REITS (not limited to office REITS)? Appreciate your insight!
Read Answer Asked by Ching on March 17, 2022
Q: I presently own Mawer US equity 108 and 150 global small caps
Would like your recommendations as to buying two more Mawer funds that are down a lot and may have some good upside in the next two/three years
Alternatively can you recommend an ETF instead of the mawer funds you choose since the etf would have lower fees
Finally would You choose the Mawer funds over the ETFs you recommend in spite of the higher Mawer fees with the expectation of better returns from Mawer ?
I would like to purchase with Canadian dollars
Thank you
Read Answer Asked by Indra on March 17, 2022
Q: In march,2021 you published a special opportunities report on 10 top picks beginning with byd,csu.
We would be pleased if you could provide an update.
Would you make any changes?



Read Answer Asked by Terry on March 17, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!